The center’s central Cambridge location is a far cry from the firm’s former R&D base in the countryside near Cheshire, England. AstraZeneca sold that site, known as Alderley Park, in 2014.

AstraZeneca has revealed the proposed designs for its new global R&D centre and corporate headquarters in Cambridge in the UK. The unveiling of the plans for an ambitious, purpose built ...

LONDON (Reuters) – AstraZeneca is closing in on a site for its new $500 million home in Cambridge, with a biomedical park just south of the English city the most likely site, property industry ...

AstraZeneca AZN-1.07%decrease; red down pointing triangle plans to spend GBP650 million ($828.8 million) on vaccine programs and various other initiatives in the U.K. The pharmaceutical company ...

Cambridge, England-based biopharmaceutical giant AstraZeneca is pouring billions of dollars into properties in the United States. The company on Tuesday announced $2B in new investment for its U.S ...